ALFA Finder| Metric | Q4 FY26 | Q3 FY26 | Q4 FY25 |
|---|---|---|---|
| Revenue from operations | 217.8 | 159.3 | 203.8 |
| Other income | 4.0 | 1.6 | 0.7 |
| Total income | 221.8 | 160.9 | 204.5 |
| Profit before exceptional items & tax | 17.6 | 0.1 | 7.3 |
| Exceptional items | 0.0 | 5.7 | 0.0 |
| Profit before tax | 17.6 | 5.9 | 7.3 |
| Net profit | 15.7 | 3.6 | 4.2 |
| Operating margin | 7.9% | 3.7% | 3.6% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | +273.80% |
|---|---|
| Net profit, quarter on quarter | +336.10% |
| Revenue, year on year | +6.90% |
NSE results filing, NSE: VALIANTORG. Figures extracted from the filing.
Valiant Organics Ltd: key numbers
- Share price
- ₹361.15
- Market cap
- ₹1,012 Cr
- Revenue (annual)
- ₹738.8 Cr
- Net profit (annual)
- ₹33.24 Cr
- P/E (TTM)
- 15.4×Sector 35.5×
- Promoter holding
- 37.89%+0.02% QoQ
- FII holding
- 0.44%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Valiant Organics Ltd
All →Valiant Organics Q2 FY27 Results: Net Profit ₹17.3 Cr, Up 203.5% YoY
Valiant Organics Ltd reported revenue from operations of ₹304.2 Cr (+93.4% YoY) and net profit of ₹17.3 Cr (+203.5% YoY) for Q2 FY27.
- Key figure
- Net profit ₹17.3 Cr · +203.5% YoY
Valiant Organics Board Meeting Date
Valiant Organics schedules a board meeting on November 5, 2026 to consider unaudited quarterly and half-year results. The trading window stays closed until November 7, 2026.
Valiant Organics Other Announcement
The company has filed its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI Regulation 31.
Valiant Organics Legal & Regulatory
Valiant Organics received an income tax rectification order for Assessment Year 2015-16, determining a net payable amount of ₹0.22 Crore.
- Value
- ₹0.22 Cr
Valiant Organics Investor Presentation: Key Takeaways
Valiant Organics presented its FY26 performance at the AGM, reporting Revenue of INR 739 Cr and EBITDA margin of 13.64%. The firm is shifting focus towards high-margin Benzene and Chlorophenol derivatives.
Valiant Organics Annual General Meeting
Valiant Organics held its 21st AGM on September 29, 2026, transacting various ordinary and special business items including re-appointments and material related party transaction approvals.